OxSonics Limited A Finalist For “Best Emerging UK Medtech Company” Award

Oxford, UK – 1 September 2017 – OBN Ltd, the membership organisation supporting the UK’s innovative life sciences companies has announced the finalists of its 8th Annual Awards covering Biotech, Medtech, Synthetic Biology and Digital Health. The OBN Awards remain proudly independent, celebrating innovation and achievement across the UK life sciences industry and recognising achievements […]

OxSonics and OrthoSon Raise Over £9.4m in Series B Equity Financing

Oxford, UK – 9th January 2017 – OxSonics® Limited today announced that over £9.4 million of Series B equity financing had been successfully raised. The funding was provided by a combination of new and existing investors, including Longwall Venture Partners, Oxford Technology Innovation EIS Fund, the University of Oxford, Winton Ventures, Perivoli Innovations as well […]

Oxford Team Wins “Outstanding Paper Award”

Oxford, UK – 15 April 2016 – a University of Oxford spin-out company developing a new generation of ultrasound-based medical devices, today announced that members of the co-founding team and R&D team of OxSonics have won the 2016 “Jorge Heller Journal of Controlled Release Outstanding Paper Award”, which specifically recognizes major advances in the delivery […]

OxSonics Wins “Best Emerging UK Medtech Company” Award

Oxford, UK – 5 October 2015 – OxSonics Limited (“OxSonics”), University of Oxford spin-out company developing a new generation of ultrasound-based medical devices, today announced it had won the award for the “Best Emerging UK Medtech Company” at the OBN annual award ceremony. The awards celebrate the key achievements within the UK’s bioscience and medical […]

OxSonics Appoints Juniper Pharma Services as Contract Development & Manufacturing Organisation

Oxford, UK – 23 June 2015 – OxSonics Limited (“OxSonics”) has entered into a long-term contract development and manufacturing partnership with Juniper Pharma Services Ltd. (“Juniper”). Juniper will support OxSonics in the formulation development, scale-up and GMP manufacturing of OxSonics’ proprietary injectable “sono-sensitive particles”. OxSonics was established in July 2013 to develop and commercialise a […]

OxSonics Featured In MoneyWeek Magazine

London, UK – 2 April 2015 – OxSonics was featured in the latest issue of MoneyWeek Magazine, the UK’s best-selling financial magazine. To view the article please visit: http://moneyweek.com/penny-sleuth-oxford-university-spin-out-oxsonics/ PDF version

MHRA Case Study Illustrates How MHRA & OxSonics Help Cancer Drugs Go The Extra Mile

London, UK – 15 January 2015 – The Medicines and Healthcare products Regulatory Agency (“MHRA”) has helped OxSonics take a big step towards developing a revolutionary generation of ultrasound devices which aim to enhance delivery of anti-cancer drugs deep into solid tumours. OxSonics Limited (“OxSonics”) was established in July 2013 to develop and commercialise a […]

OxSonics Limited Nominated & Shortlisted For “Best New Medtech Development Programme” Award

Oxford, UK – 21 August 2014 – OxSonics Limited (“OxSonics”), a University of Oxford spin-out company developing a new generation of ultrasound-based medical devices, today announced it has been nominated and shortlisted as a finalist in the national OBN awards in the category of “Best New Medtech Development Programme”. OxSonics was established in July 2013 […]

OxSonics Limited Secures £2.1m Biomedical Catalyst Award

Oxford, UK – 16 June 2014 OxSonics Limited (“OxSonics”), a University of Oxford spin-out company developing a new generation of ultrasound-based medical devices, today announced it has successfully secured a major £2.1 million Biomedical Catalyst award from the UK’s innovation agency, the Technology Strategy Board. OxSonics was established in July 2013 to develop and commercialise […]

OxSonics Limited Completes Series A Equity Financing

Oxford, UK – 17 January 2014 OxSonics Limited (“OxSonics”), a University of Oxford spin-out company developing a new generation of ultrasound-based medical devices, closes a series A equity financing of £2.7 million. OxSonics was established in July 2013 to develop and commercialise a range of medical devices including “SonoTran”, an innovative drug delivery platform. SonoTran […]